Astellas Sponsored Expert Discussion- MD Education Acute Myelogenous Leukemia 1 Min Read6 The discussion focuses on the changing landscape of treatment for mutated acute myeloid leukemia (AML). The speaker emphasizes the significance…
Eytan M. Stein, MD- Menin Inhibitors for KMT2A and NPM1 Mutations Acute Myelogenous Leukemia 1 Min Read22 Eytan M. Stein, MD – Leukemia & Early Drug Development Specialist – David H. Koch Center for Cancer Care at Memorial…
